Give it to us straight, docs tell pharma advertisers by Beth Snyder Bulik Thursday, January 3, 2019 Physicians prefer simple and clear messages from pharma advertisers, according to a new survey, and even they are confused by some ads.
Proposal to force prices in ads draws big pharma response by Beth Snyder Bulik Wednesday, January 2, 2019 Pfizer, Eli Lilly, Sanofi and Johnson & Johnson chimed in on the federal government’s plan to tag pharma TV ads with drug prices.
Pharma innovation challenges continue to thrive by Beth Snyder Bulik Wednesday, December 19, 2018 Innovation challenges continue to grow, but don't worry about brain drain. There are plenty of ideas still to go around.
Expect more transparency around advocacy partnerships in 2019 by Beth Snyder Bulik Wednesday, December 19, 2018 Advocacy groups and pharma companies often work hand in hand, but this year saw some of the shine wear off.
Pharma marketing trends in politics and tech will continue into 2019 by Beth Snyder Bulik Wednesday, December 19, 2018 In this issue, FiercePharmaMarketing looks back—and forward—to the focal points and features of 2018 that will keep trending in 2019.
Cancer marketing spreads across the media landscape by Beth Snyder Bulik Wednesday, December 19, 2018 Pharma's push in cancer marketing isn't done yet. Expect more ads across the media landscape as new cancer-fighters come to market.
Politicians aim to keep drug prices in ads on front burner by Beth Snyder Bulik Wednesday, December 19, 2018 Lawmakers on both sides of the aisle refuse to let go of the proposal to force drug pricing into consumer advertising, but they're not the only ones.
Trend 2019: Digital therapeutics from pharma by Beth Snyder Bulik Wednesday, December 19, 2018 As patients continue taking a more active role in healthcare, pharma's interest in digital therapeutics, already on a roll, will only accelerate.
Chief digital officers descend on Big Pharma by Beth Snyder Bulik Wednesday, December 19, 2018 Chief digital officers in pharma are here to stay as they transform business and marketing practices.
What to do when an exposé tanks your stock? J&J's going DTC by Beth Snyder Bulik Monday, December 17, 2018 Johnson & Johnson launched new print and online ad this week in defense of its flagship baby powder after damaging news reports.